Latest news with #VitalHub
Yahoo
28-04-2025
- Business
- Yahoo
VitalHub Announces Q1 2025 Conference Call Date
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the 'Company' or 'VitalHub') is pleased to announce that it will release its financial results for its first quarter 2025 ended March 31, 2025, after market close on May 8, 2025. The Company will hold a conference call on May 9, 2025, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow. To register for the conference call please visit: About VitalHub VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 500 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX: VHI) (OTCQX: VHIBF), please visit and connect with us on LinkedIn. Contact Information Christian Sgro, CPA, CA, CFAHead of IR and M&A Specialist(365) Dan MatlowChief Executive Officer, Director(416) in to access your portfolio
Yahoo
14-04-2025
- Business
- Yahoo
VitalHub to acquire Induction Healthcare
Canadian software company VitalHub has consented to the proposed terms for a cash purchase of the entire issued and forthcoming share capital of Induction Healthcare Group. The acquisition, which is to be executed via a court-sanctioned scheme of arrangement, values Induction at approximately £9.7m ($12.73m). Each shareholder of the company will receive £0.10 in cash for every share held. Induction delivers software solutions that focus on patient experience and healthcare delivery via hospitals. Its primary products, Zesty and Attend Anywhere, are designed to facilitate remote and face-to-face healthcare services. Patient engagement platform Zesty integrates with hospital systems to offer smart appointment management and digital services while Attend Anywhere provides secure video consultation capabilities. The acquisition is seen as a strategic move by VitalHub to complement and broaden its product offering. The integration of Zesty is particularly anticipated to add value to VitalHub's asset portfolio. In addition, the acquisition presents VitalHub with the opportunity to expand its product reach into new markets, including the UK, Canada, Europe, the Middle East, and Australia. Induction is also expected to benefit from joining a larger global enterprise. The deal is set to be finalised by 31 July 2025, with a final cut-off date of 30 September 2025. Induction's financial performance for the year ended 31 March 2024 showed revenues of £14.4m, a gross margin of 78.4%, and an adjusted EBITDA loss of £0.3m. Zesty and Attend Anywhere contributed £4.9m and £8.8m in revenues, respectively. Edwin Coe will serve as VitalHub's legal adviser while Cavendish Capital Markets is the financial adviser for the acquisition. In July 2024, VitalHub consented to the acquisition of MedCurrent, a provider of clinical decision support systems, for a sum that could reach up to C$34m. "VitalHub to acquire Induction Healthcare" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
27-03-2025
- Business
- Yahoo
VitalHub Reports Fourth Quarter and Annual 2024 Results
Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1 millionTotal Revenue up 51% YoY to $20.6 millionAdjusted EBITDA ⁽²⁾ up 27% YoY to $5.0 million TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the 'Company' or 'VitalHub') (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for the year ended December 31, 2024 with the Canadian securities authorities. These documents may be viewed under the Company's profile at 'We are pleased to report strong full year results, highlighted by annual 15% organic ARR⁽¹⁻²⁾ growth and 26% adjusted EBITDA⁽²⁾ margins,' said Dan Matlow, CEO of VitalHub. 'We are seeing momentum build with our growing platform functionality and reputational awareness. Our record-breaking sequential net new organic ARR⁽¹⁻²⁾ in the fourth quarter of $2.6 million was well-balanced across our leading EHR suite in Canada and patient flow solutions in the UK. We see opportunities for sustained growth rates in our core geographies as we cross-sell complementary solutions and add new clients.' 'We closed four acquisitions in 2024, adding $17.9 million of acquisition ARR⁽¹⁻²⁾ and adding new solutions and team members that we are proud to have at VitalHub. Integration efforts from a product, infrastructure, and go-to-market perspective are well underway, including the fourth quarter 2024 acquisitions of Strata and MedCurrent. We see areas for potential enhanced revenue growth and operational efficiency, with our goal of steadily expanding our cash flow margin over the next twelve to eighteen months post-acquisition, as we have successfully accomplished historically.' 'Our current pro forma cash balance is approximately $90 million, with strong positive cash generation and access to debt if needed. We are prepared to deploy capital on M&A, and we currently expect the pace of activity from 2024 to continue through 2025. We are proud of all growth and achievements to date, and are excited for the year ahead.' VitalHub's quarterly investor conference call will take place on Friday, March 28, 2025, at 9:00AM EST. To register for the call, please visit: Fourth Quarter 2024 Highlights ARR⁽¹⁻²⁾ at December 31, 2024 was $71,054,210 as compared to $53,452,108 at September 30, 2024, an increase of $17,602,101 or 33%. ARR⁽¹⁻²⁾ growth during the quarter was attributable to: Organic growth of $2,609,657 or 5%; Acquisition growth of $14,600,000 or 27%; Gain of $392,445 or 1% due to the fluctuations in foreign exchange rates. Revenue of $20,590,779 as compared to $13,603,419 in the equivalent prior year period, an increase of $6,987,360 or 51%. Gross profit as a percentage of revenue was 81% compared to 83% in the equivalent prior year period. Net income before income taxes of $173,000 (including $2,588,292 of business acquisition, restructuring and integration costs) as compared to net income before income taxes of $1,984,246 (including $306,741 of business acquisition, restructuring and integration costs) in the equivalent prior year period, a decrease of $1,811,246 or 91%. EBITDA⁽²⁾ of $1,875,370 compared to $2,992,273 in the equivalent prior year period, a decrease of $1,116,903 or 37%. Adjusted EBITDA⁽²⁾ of $5,046,758 or 25% of revenue, compared to $3,985,553 or 29% of revenue in the equivalent prior year period, an increase of $1,061,205 or 27%. On October 4, 2024, the Company acquired all of the issued and outstanding shares of MedCurrent Corporation and its subsidiaries. On October 29, 2024, the Company acquired all of the issued and outstanding shares of Strata Health Solutions Inc. Annual 2024 Highlights ARR⁽¹⁻²⁾ at December 31, 2024 was $71,054,210 as compared to $44,573,739 at December 31, 2023, an increase of $26,480,470 or 59%. ARR ⁽¹⁻²⁾ growth during the year was attributable to: Organic growth of $6,475,919 or 15%; Acquisition growth of $17,911,500 or 40%; Gain of $2,093,051 or 5% due to the fluctuations in foreign exchange rates. Revenue of $68,594,310 as compared to $52,508,298 in the prior year, an increase of $16,086,012 or 31%. Gross profit as a percentage of revenue was 81% compared to 82% in the prior year. Net income before income taxes of $5,895,758 (including $5,213,044 of business acquisition, restructuring, and integration costs) as compared to net income before income taxes of $5,327,733 (including $1,534,835 of business acquisition, restructuring, and integration costs) in the prior year, an increase of $568,025 or 11%. EBITDA⁽²⁾ of $9,950,872 compared to $9,887,842 in the prior year, an increase of $63,030 or 1%. Adjusted EBITDA⁽²⁾ of $17,840,272 or 26% of revenue, compared to $13,291,526 or 25% of revenue in the prior year, an increase of $4,548,746 or 34%. Cash on hand at December 31, 2024 was $56,574,904 compared to $33,480,018 as at December 31, 2023. Subsequent to the quarter, the Company completed a bought deal public offering pursuant to which 3,165,145 common shares were issued at $10.90 per common share for total gross proceeds to the Company of approximately $34.5 million. (1) The Company defines annual recurring revenue ('ARR') as the recurring revenue expected based on yearly subscriptions of the renewable software license fees and maintenance services.(2) Non-IFRS measure. Disclaimers and reconciliations can be found in SEDAR filings. Selected Financial Information Three months ended Year ended December 31, 2024 % Revenue December 31, 2023 % Revenue Change December 31, 2024 % Revenue December 31, 2023 % Revenue Change $ $ % $ $ % Revenue 20,590,779 100% 13,603,419 100% 51% 68,594,310 100% 52,508,298 100% 31% Cost of sales 3,841,539 19% 2,364,543 17% (62%) 13,099,877 19% 9,697,998 18% (35%) Gross profit 16,749,240 81% 11,238,876 83% 49% 55,494,433 81% 42,810,300 82% 30% Operating expenses General and administrative 5,442,656 26% 2,911,708 21% (87%) 15,451,016 23% 11,765,148 22% (31%) Sales and marketing 1,685,221 8% 1,394,948 10% (21%) 6,766,434 10% 5,883,267 11% (15%) Research and development 4,189,941 20% 3,188,172 23% (31%) 15,227,119 22% 12,169,285 23% (25%) Depreciation of property and equipment 123,147 1% 76,496 1% (61%) 375,838 1% 318,866 1% (18%) Depreciation of right-of-use assets 111,156 1% 101,115 1% (10%) 438,068 1% 399,715 1% (10%) Share-based compensation 684,034 3% 220,494 2% (210%) 2,344,464 3% 1,058,919 2% (121%) Deferred share-based compensation - 0% - 0% 0% - 0% 97,560 0% 100% Foreign currency loss (gain) 384,805 2% (241,505 ) (2%) 259% 209,733 0% (296,824 ) (1%) (171%) Other expenses (income) Amortization of intangible assets 1,730,224 8% 1,067,885 8% (62%) 5,149,018 8% 4,259,113 8% (21%) Business acquisition, restructuring and integration costs 2,588,292 13% 306,741 2% (744%) 5,213,044 8% 1,534,835 3% (240%) (Gain) loss on change in fair value of contingent consideration (100,938 ) (0%) 466,045 3% 122% 331,892 0% 712,370 1% 53% Interest expense and accretion (net of interest income) (270,367 ) (1%) (252,294 ) (2%) 7% (1,950,815 ) (3%) (489,566 ) (1%) 298% Interest expense from lease liabilities 8,210 0% 14,825 0% 45% 43,005 0% 71,981 0% 40% Gain on disposal of property and equipment (141 ) (0%) - 0% 0% (141 ) (0%) (2,102 ) (0%) 93% Current and deferred income taxes (614,244 ) (3%) 1,045,457 8% (159%) 2,896,714 4% 778,248 1% 272% Net income 787,244 4% 938,789 7% (16%) 2,999,044 4% 4,549,485 9% (34%) EBITDA (Non-IFRS measure) 1,875,370 9% 2,992,273 22% (37%) 9,950,872 15% 9,887,842 19% 1% Adjusted EBITDA (Non-IFRS measure) 5,046,758 25% 3,985,553 29% 27% 17,840,272 26% 13,291,526 25% 34% Annual recurring revenue (Non-IFRS measure) 71,054,210 44,573,739 59% 71,054,210 44,573,739 59% Term licences, maintenance and support revenue 17,673,596 86% 11,302,366 83% 56% 57,070,350 83% 42,332,253 81% 35% As at December 31, 2024 December 31, 2023 $ $ Cash balance 56,574,904 33,480,018 Deferred revenue 35,636,002 21,049,975 About VitalHub VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 500 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX: VHI) (OTCQX: VHIBF), please visit and connect with us on LinkedIn. Contact Information Christian Sgro, CPA, CA, CFAHead of IR and M&A Specialist(365) Dan MatlowChief Executive Officer, Director(416) Cautionary Statement Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or in to access your portfolio
Yahoo
17-03-2025
- Business
- Yahoo
VitalHub Announces Q4 2024 Conference Call Date
TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the 'Company' or 'VitalHub') is pleased to announce that it will release its financial results for its fourth quarter 2024 ended December 31, 2024, after market close on March 27, 2025. The Company will subsequently hold a conference call via Zoom on March 28, 2025, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow. To register for the conference call please visit: About VitalHub VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 500 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX: VHI) (OTCQX: VHIBF), please visit and connect with us on LinkedIn. Contact Information Christian Sgro, CPA, CA, CFAHead of IR and M&A Specialist(365) Dan MatlowChief Executive Officer, Director(416) Cautionary Statement Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or in to access your portfolio
Yahoo
05-03-2025
- Business
- Yahoo
3 TSX Stocks Perfect for First-Time Investors
Written by Robin Brown at The Motley Fool Canada With so much uncertainty facing TSX stocks, it can be a challenge for a new investor to know how to invest right now. One great way to help manage that risk is to own a diverse portfolio. A mix of stocks with exposure to different industries, sectors, and assets can help prevent the risk of permanent capital loss. As you gain experience, you can start to narrow in on which market segments match your interests and risk tolerance. If you are looking for some TSX stocks to get started with, here are three stocks to look at adding. Dividend stocks are a great place to start. New investors often enjoy the tangible returns that dividends bring. What's better than cash in your pocket just for owning a stock? If you want an ultra-safe stock, Fortis (TSX:FTS) is a good bet. You don't own this stock for a big capital gain. FTS stock has only risen by about 4% per annum for the past five years. However, it has steadily paid and grown its ~4% dividend yield. Fortis is a low beta stock. This means it is generally less volatile than the broader market. Its transmission utilities across North America deliver stable and predictable results. This has fuelled 50-plus years of consecutive dividend increases. It is not exciting, but it is very safe (and you collect passive income along the way). Small cap stocks are a great place to invest if you don't mind a bit more risk and higher reward. VitalHub (TSX:VHI) has the potential to deliver great long-term returns in the future. The software firm provides solutions to the healthcare industry. Its technology helps clinics and hospitals become more effective and efficient. The entire industry is ripe for disruption. That gives VitalHub a long runway ahead. The company has grown by making good acquisitions and smart market expansion. With a cash-rich balance sheet, it should be able to keep growing by adding smart software companies to its portfolio. It has operations across the world, so you are not at risk from exposure to any one market. VitalHub is not the cheapest stock in terms of valuation. However, if it can continue to execute like it has in the past few years, it could deliver strong double-digit annual returns ahead. You don't always need to increase risk to get better rewards. Constellation Software (TSX:CSU) is a great example. The software firm has steadily compounded returns by over 30% for more than 18 years. However, today its stock trades for over $4,850 per share. CSU stock has a market cap over $100 billion. The good news is that you can buy its little brother, (TSXV:TOI), for only $139 per share. Topicus is consolidating small, specialized software businesses around Europe and abroad. Given what is happening in the U.S., this is a way to broaden your geographic exposure. Topicus has made some great acquisitions early on in 2025. The spinoff generates a lot of excess cash and has a very strong balance sheet. It's a good bet if you want to mirror Constellation's growth profile for the years to come. The post 3 TSX Stocks Perfect for First-Time Investors appeared first on The Motley Fool Canada. Before you buy stock in Constellation Software, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Constellation Software wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,058.57!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*. See the Top Stocks * Returns as of 2/20/25 More reading 10 Stocks Every Canadian Should Own in 2024 [PREMIUM PICKS] It's Time to Buy: 1 Canadian Stock That Hasn't Been This Cheap in Years Where to Invest Your $7,000 TFSA Contribution 3 No-Brainer TSX Stocks to Buy With $300 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Robin Brown has positions in Constellation Software, and Vitalhub. The Motley Fool has positions in and recommends and Vitalhub. The Motley Fool recommends Constellation Software and Fortis. The Motley Fool has a disclosure policy. 2025
